Find Lawyers Today, Get Legal Help.
Home >> Legal News >> PREVENTING MEDICAL ERRORS AVOIDING DANGEROUS MIXUPS BETWEEN AMPHOTERICIN FORMULATIONS
FDA News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
PREVENTING MEDICAL ERRORS AVOIDING DANGEROUS MIXUPS BETWEEN AMPHOTERICIN FORMULATIONS
November 7, 2007
In the wake of two recent patient deaths in the UK, the Institute for Safe Medication Practices (ISMP) is again warning healthcare professionals about potentially fatal mixups between various formulations of amphotericin B, which is used intravenousl...Related FDA Stories:
- New Medical Products New Colchicine Product and Dosing Regimen..
- Recalls and Safety Alerts Preventing Meningitis in Children with Cochlear I..
- New from FDA Drug Safety Newsletter now Available..
Additional Legal Resources:
Complete the Form Below and Talk to Experienced Lawyers
